Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.

about

Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.

Item

http://www.wikidata.org/entity/Q50419857

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Potential lymphangiogenesis th ...... giogenesis therapies-A review.

@en

Potential lymphangiogenesis th ...... giogenesis therapies-A review.

@nl

type

Item

label

Potential lymphangiogenesis th ...... giogenesis therapies-A review.

@en

Potential lymphangiogenesis th ...... giogenesis therapies-A review.

@nl

prefLabel

Potential lymphangiogenesis th ...... giogenesis therapies-A review.

@en

Potential lymphangiogenesis th ...... giogenesis therapies-A review.

@nl

P1476

Potential lymphangiogenesis th ...... ngiogenesis therapies-A review

@en

P2093

Andrius Kazlauskas

http://www.w3.org/2001/XMLSchema#string

Charles Yu

http://www.w3.org/2001/XMLSchema#string

Dimitri T Azar

http://www.w3.org/2001/XMLSchema#string

Ellen C Qin

http://www.w3.org/2001/XMLSchema#string

Hyunjoon Kong

http://www.w3.org/2001/XMLSchema#string

Kyu-Yeon Han

http://www.w3.org/2001/XMLSchema#string

Mario Montana

http://www.w3.org/2001/XMLSchema#string

Mark I Rosenblatt

http://www.w3.org/2001/XMLSchema#string

Michael Yamakawa

http://www.w3.org/2001/XMLSchema#string

Susan J Doh

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

Lymph vessels: the forgotten second circulation in health and disease

Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis

Immunomodulatory roles of lymphatic vessels in cancer progression

Intravital Imaging Reveals Dynamics of Lymphangiogenesis and Valvulogenesis.

Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules

P304

1769-1798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MED.21496

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Samuel M Santosa

Jin-Hong Chang

P577

2018-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29528507

http://www.w3.org/2001/XMLSchema#string

P921

lymphangiogenesis

P932

6135718

http://www.w3.org/2001/XMLSchema#string